EXACT SCIENCES CORPORATION
NASDAQ: EXAS (Exact Sciences Corporation)
最近更新时间: 18小时之前59.40
3.29 (5.86%)
| 前收盘价格 | 56.11 |
| 收盘价格 | 56.04 |
| 成交量 | 2,733,198 |
| 平均成交量 (3个月) | 2,411,898 |
| 市值 | 10,993,514,496 |
| 预期市盈率 (P/E Forward) | 2.50 |
| 价格/销量 (P/S) | 4.04 |
| 股市价格/股市净资产 (P/B) | 3.42 |
| 52周波幅 | |
| 利润日期 | 19 Feb 2025 - 24 Feb 2025 |
| 营业毛利率 | -7.95% |
| 营业利益率 (TTM) | -2.61% |
| 稀释每股收益 (EPS TTM) | -1.16 |
| 季度收入增长率 (YOY) | 12.80% |
| 总债务/股东权益 (D/E MRQ) | 86.62% |
| 流动比率 (MRQ) | 2.12 |
| 营业现金流 (OCF TTM) | 233.02 M |
| 杠杆自由现金流 (LFCF TTM) | 97.26 M |
| 资产报酬率 (ROA TTM) | -2.16% |
| 股东权益报酬率 (ROE TTM) | -6.76% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 混合的 | 混合的 |
| Diagnostics & Research (全球的) | 混合的 | 混合的 | |
| 股票 | Exact Sciences Corporation | 看跌 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 2.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 0.5 |
| 平均 | -0.50 |
|
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Mid Core |
| 内部持股比例 | 1.01% |
| 机构持股比例 | 101.78% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 90.00 (Bernstein, 51.52%) | 购买 |
| 中 | 73.50 (23.74%) | |
| 低 | 60.00 (Evercore ISI Group, 1.01%) | 购买 |
| 平均值 | 73.00 (22.90%) | |
| 总计 | 14 购买 | |
| 平均价格@调整类型 | 56.84 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| B of A Securities | 13 Dec 2024 | 72.00 (21.21%) | 购买 | 61.25 |
| BTIG | 26 Nov 2024 | 75.00 (26.26%) | 购买 | 60.10 |
| 06 Nov 2024 | 65.00 (9.43%) | 购买 | 54.72 | |
| TD Cowen | 26 Nov 2024 | 86.00 (44.78%) | 购买 | 60.10 |
| 06 Nov 2024 | 82.00 (38.05%) | 购买 | 54.72 | |
| Piper Sandler | 11 Nov 2024 | 75.00 (26.26%) | 购买 | 51.33 |
| Baird | 06 Nov 2024 | 67.00 (12.79%) | 购买 | 54.72 |
| Benchmark | 06 Nov 2024 | 65.00 (9.43%) | 购买 | 54.72 |
| Canaccord Genuity | 06 Nov 2024 | 75.00 (26.26%) | 购买 | 54.72 |
| 29 Oct 2024 | 95.00 (59.93%) | 购买 | 69.64 | |
| Citigroup | 06 Nov 2024 | 75.00 (26.26%) | 购买 | 54.72 |
| Craig-Hallum | 06 Nov 2024 | 65.00 (9.43%) | 购买 | 54.72 |
| Evercore ISI Group | 06 Nov 2024 | 60.00 (1.01%) | 购买 | 54.72 |
| 01 Oct 2024 | 80.00 (34.68%) | 购买 | 68.04 | |
| Goldman Sachs | 06 Nov 2024 | 65.00 (9.43%) | 购买 | 54.72 |
| Jefferies | 06 Nov 2024 | 85.00 (43.10%) | 购买 | 54.72 |
| Stifel | 06 Nov 2024 | 67.00 (12.79%) | 购买 | 54.72 |
| Bernstein | 30 Oct 2024 | 90.00 (51.52%) | 购买 | 70.46 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合